Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5703226 | American Journal of Ophthalmology | 2017 | 25 Pages |
Abstract
Anti-VEGF treatment is often experienced with some anxiety related to treatment, regardless of the number of injections received. Clinical levels of depression seem to be more frequent in patients at early stages of anti-VEGF treatment. Strategies to improve patient experience of treatment and minimize morbidity are suggested.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Hugo Senra, Konstantinos Balaskas, Neda Mahmoodi, Tariq Aslam,